Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 64Gastrointestinal 52Thoracic 30Gynecologic 29Genitourinary 28Other hematologic neoplasm 21Tumor-Agnostic 18Other solid neoplasm 17Lymphoid 17Other 14Dermatologic 10Head & Neck 7Sarcoma 6Other neoplasm 5CNS 5Plasma cell 3Myeloid 1Endocrine 1

Conditions

Multiple Myeloma 3Lymphoma 2Genital Neoplasms, Female 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Dexamethasone 881Bortezomib 478Lenalidomide 467Cyclophosphamide 367Melphalan 275Calcium Dobesilate 264daratumumab 240pomalidomide 215carfilzomib 188fludarabine phosphate 141fludarabine 137Thalidomide 125Peripheral Blood Stem Cell Transplantation 120Filgrastim 115ixazomib 94Mycophenolic Acid 91Granulocyte Colony-Stimulating Factor 90Busulfan 89Whole-Body Irradiation 88dexamethasone acetate 87Tacrolimus 79dexamethasone 21-phosphate 74isatuximab 68Cyclosporine 68auricularum 67Prednisone 67elotuzumab 63belantamab mafodotin 59Antilymphocyte Serum 56Etoposide 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Methods × Plasma cell × Clear all
NCT03141437 2026-04-24

Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer

M.D. Anderson Cancer Center

Phase NA Active not recruiting
130 enrolled
BreastGastrointestinalLymphoidPlasma cell

Breast Neoplasms, Genital Neoplasms, Female, Lymphoma, Multiple Myeloma, Colorectal Neoplasms

NCT06063603 2025-09-18

ASCENT

Mayo Clinic

Phase NA Completed
51 enrolled 8 charts
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT02129569 2017-03-20

Psychoeducational and Behavioral Strategies in Reducing Distress and Anxiety in Patients With Multiple Myeloma and Their Family Caregivers

Case Comprehensive Cancer Center

Phase NA Completed
30 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡